The vector of anti-TF chimeric antigen receptor (CAR) is constructed for the engineering of T cells to target human TF. The T cells are genetically modified through transduction with a lentiviral vector expressing hFVIIL linked to CD3-zeta and b2c signaling domains. And the vector product was designed for modifying T cell, modified T cells for the treatment of tumors.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
|CAR-T-2-L406-2Z||TF h(CD28-CD3ζ) CAR, [T]|
|CAR-T-3-L406-2BZ||TF h(CD28-41BB-CD3ζ) CAR, [T]|
|CAR-T-2-L406-2G||TF h(CD28-FcεRIγ) CAR, [T]|
|CAR-T-2-L406-4G||TF h(CD4-FcεRIγ) CAR, [T]|
|CAR-T-1-L406-G||TF h(FcεRIγ) CAR, [T]|
|TCR-C250Z||Mouse anti-TF T cell receptor (D10), pCDTCR1|
|CAR-T-2-L406-BZ||TF h(41BB-CD3ζ) CAR, [T]|
|CAR-T-1-L406-Z||TF h(CD3ζ) CAR, [T]|
|CAR-T-3-L406-2XZ||TF h(CD28-OX40-CD3ζ) CAR, [T]|
|CAR-T-2-L406-4Z||TF h(CD4-CD3ζ) CAR, [T]|
|CAR-T-1-L406-2||TF h(CD28) CAR, [T]|
|CAR-T-2-L406-8Z||TF h(CD8-CD3ζ) CAR, [T]|
Copyright © 2007 - 2017 Creative Biolabs. All Rights Reserved